CODX Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

126.00K

-15.62%

-3.600

-66.67%

163.50K

+225.18%

-3.750

-47.92%

166.50K

+2.2%

-3.000

-56.52%

Estimates Revision

The market is revising Downward the revenue expectations for Co-Diagnostics, Inc. (CODX) for FY2025, with the revenue forecasts being adjusted by -5.56% over the past three months. During the same period, the stock price has changed by -52.56%.

Revenue Estimates for FY2025

Revise Downward

-5.56%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-7.28%

In Past 3 Month

Stock Price

Go Down

-52.56%

In Past 3 Month

2 Analyst Rating

Wall Street analysts forecast CODX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CODX is 1.50 USD with a low forecast of 1.50 USD and a high forecast of 1.50 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

1 Hold

0 Sell

Moderate Buy

Current: 0.000

Low

1.50

Averages

1.50

High

1.50

Current: 0.000

Low

1.50

Averages

1.50

High

1.50

Maxim

NULL -> Buy

initiated

$1.50

2025-11-26

Reason

Maxim

Price Target

$1.50

2025-11-26

initiated

NULL -> Buy

Reason

Maxim initiated coverage of Co-Diagnostics with a Buy rating and $1.50 price target.

HC Wainwright & Co.

Yi Chen

Hold

Maintains

$1.5 → $1

2025-03-28

Reason

HC Wainwright & Co.

Yi Chen

Price Target

$1.5 → $1

2025-03-28

Maintains

Hold

Reason

Valuation Metrics

The current forward P/E ratio for Co-Diagnostics Inc (CODX.O) is -0.42, compared to its 5-year average forward P/E of 6.07. For a more detailed relative valuation and DCF analysis to assess Co-Diagnostics Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

6.07

Current PE

-0.42

Overvalued PE

23.81

Undervalued PE

-11.67

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

5.50

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

23.69

Undervalued EV/EBITDA

-12.70

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

5Y Average PS

13.07

Current PS

17.97

Overvalued PS

25.54

Undervalued PS

0.60

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

CODX News & Events

Events Timeline

No data

News

9.0

2025-12-30PRnewswire

Co-Diagnostics Executes 1-for-30 Reverse Stock Split to Maintain Nasdaq Listing

3.5

2025-12-29PRnewswire

Co-Diagnostics Secures Australian Patent for PCR Testing Platform

3.5

2025-12-29Newsfilter

Co-Diagnostics Secures Australian Patent for PCR Testing Platform

People Also Watch

Frequently Asked Questions

What is Co-Diagnostics Inc (CODX) stock price today?

The current price of CODX is 6.12 USD — it has increased 0 % in the last trading day.

What is Co-Diagnostics Inc (CODX)'s business?

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.

What is the price predicton of CODX Stock?

What is Co-Diagnostics Inc (CODX)'s revenue for the last quarter?

Co-Diagnostics Inc revenue for the last quarter amounts to 145.38K USD, decreased -77.32 % YoY.

What is Co-Diagnostics Inc (CODX)'s earnings per share (EPS) for the last quarter?

Co-Diagnostics Inc. EPS for the last quarter amounts to -0.16 USD, decreased -50.00 % YoY.

What changes have occurred in the market's expectations for Co-Diagnostics Inc (CODX)'s fundamentals?

How many employees does Co-Diagnostics Inc (CODX). have?

Co-Diagnostics Inc (CODX) has 132 emplpoyees as of January 09 2026.

What is Co-Diagnostics Inc (CODX) market cap?

Today CODX has the market capitalization of 12.82M USD.